These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6894571)

  • 1. Selective binding of sucralfate to gastric ulcer in man.
    Nakazawa S; Nagashima R; Samloff IM
    Dig Dis Sci; 1981 Apr; 26(4):297-300. PubMed ID: 6894571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific binding of sucralfate in gastric ulcer and gastritis.
    Sasaki H; Tsunoda Y; Hinohara Y; Nakano H; Miura K; Hirayama C
    Clin Ther; 1983; 5(5):545-57. PubMed ID: 6688556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective binding of sucralfate to ulcer lesion. II. Experiments in rats with gastric ulcer receiving 14C-sucralfate or potassium 14C-sucrose sulfate.
    Nagashima R; Hinohara Y; Hirano T; Tohira Y; Kamiyama H
    Arzneimittelforschung; 1980; 30(1):84-8. PubMed ID: 6892777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective binding of sucralfate to ulcer lesion. I. Experiments in rats with acetic acid-induced gastric ulcer receiving unlabelled sucralfate.
    Nagashima R; Hirano T
    Arzneimittelforschung; 1980; 30(1):80-3. PubMed ID: 6892776
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of food and antacid on binding of sucralfate to normal and ulcerated gastric and duodenal mucosa in rats.
    Giesing DH; Bighley LD; Iles RL
    J Clin Gastroenterol; 1981; 3(Suppl 2):111-6. PubMed ID: 6895642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective binding of sucralfate to endoscopic mucosal resection-induced gastric ulcer: evaluation of aluminium adherence.
    Itoh T; Kusaka K; Kawaura K; Kashimura K; Yamakawa J; Takahashi T; Kanda T
    J Int Med Res; 2004; 32(5):520-9. PubMed ID: 15458285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of an antiulcer drug, sucralfate (a basic aluminum salt of sulfated disaccharide), on experimental gastric lesions and gastric secretion in rats.
    Okabe S; Takeuchi K; Kunimi H; Kanno M; Kawashima M
    Dig Dis Sci; 1983 Nov; 28(11):1034-42. PubMed ID: 6688779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sucralfate: pharmacokinetics, metabolism and selective binding to experimental gastric and duodenal ulcers in animals.
    Steiner K; Bühring KU; Faro HP; Garbe A; Nowak H
    Arzneimittelforschung; 1982; 32(5):512-8. PubMed ID: 6896647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sucralfate: development of a new concept of anti-ulcer treatment. Review of its pharmacodynamic properties].
    Gorget C
    Rev Med Interne; 1985 Jun; 6(3):313-9. PubMed ID: 3901171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of sucralfate to duodenal ulcer in man.
    Sasaki H; Hinohara Y; Tsunoda Y; Nagashima R
    Scand J Gastroenterol Suppl; 1983; 83():13-4. PubMed ID: 6579630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective adherence of a sucralfate-tetracycline complex to gastric ulcers: implications for the treatment of Helicobacter pylori.
    Yokel RA; Dickey KM; Goldberg AH
    Biopharm Drug Dispos; 1995 Aug; 16(6):475-9. PubMed ID: 7579029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sucralfate: antipeptic, antiulcer activities and antagonism of gastric emptying.
    Borella LE; Seethaler K; Lippmann W
    Arzneimittelforschung; 1979; 29(5):793-8. PubMed ID: 387045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective binding of sucralfate to ulcer lesion. III. Experiments in rats with duodenal ulcer receiving 14C-sucralfate.
    Nagashima R; Hinohara Y; Hirano T
    Arzneimittelforschung; 1980; 30(1):88-91. PubMed ID: 6892778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic evaluation of the effect of sucralfate therapy and other clinical parameters on the recurrence rate of gastric ulcers.
    Miyake T; Ariyoshi J; Suzaki T; Oishi M; Sakai M; Ueda S
    Dig Dis Sci; 1980 Jan; 25(1):1-7. PubMed ID: 6986240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal injury and gamma-irradiation produce persistent gastric ulcers in the rabbit. Evaluation of antiulcer drug binding to experimental ulcer sites.
    Yokel RA; Dickey KM
    Gastroenterology; 1991 May; 100(5 Pt 1):1201-5. PubMed ID: 2013369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and In vivo evaluations of a tableted antacid and sucralfate, a new antiulcer agent.
    McGraw BF; Hesterlee EJ; Lanza FL; Tesler MA
    Am J Gastroenterol; 1981 Nov; 76(5):412-5. PubMed ID: 6895973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does basic aluminum sucrose sulfate affect blood coagulability?
    Mcgraw BF; Hesterlee EJ; Gitomer SL; Hollander DH
    Res Commun Chem Pathol Pharmacol; 1980 Nov; 30(2):373-6. PubMed ID: 6893754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sucralfate. A review of its pharmacodynamic properties and therapeutic use in peptic ulcer disease.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1984 Mar; 27(3):194-209. PubMed ID: 6368184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sucralfate, a basic aluminum salt of sucrose sulfate. IV. Interaction with enzyme pepsin.
    Yoshida N; Terao N; Nagashima R
    Arzneimittelforschung; 1980; 30(1):78-80. PubMed ID: 6768370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer. A randomized, controlled trial.
    Agrawal NM; Roth S; Graham DY; White RH; Germain B; Brown JA; Stromatt SC
    Ann Intern Med; 1991 Aug; 115(3):195-200. PubMed ID: 1905501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.